OBJECTIVE: To evaluate the understanding of the population on prostate cancer screening. DESIGN: Descriptive study. SETTING: Primary care teams in the province of Barcelona, Spain, from april to september 2005. PARTICIPANTS AND CONTEXT: Men between 50 and 70 years old without prostate symptoms and seen in the clinics of 12 primary care teams. METHOD: Systematic sample. VARIABLES: age, marital status, educational level, and self-perceived health status. Appraisal of knowledge through a 14-question questionnaire referring to the key ideas, previously defined by a group of experts, requisite before deciding on prostate cancer screening. RESULTS: N=221. Mean age, 59.9 (SD, 5.9); educational level, primary or lower: 63.4%; 89.1% (95% CI, 84.4-92.6) did not have sufficient knowledge about prostate cancer screening. In the questions on what PSA is and what it is for, over 50% said they did not know; 63.3% recognised that prostate cancer was a highly prevalent illness; 84.6% replied that early detection of prostate cancer avoids deaths; 49.8% did not know whether the doctor had doubts on this question; and 38.9% thought he didn't. There were no differences in knowledge for any of the variables studied. CONCLUSIONS: Although prostate cancer screening is widely known about, the information of the population is scant and often wrong. Existing scientific uncertainty on the use of screening is the aspect that is least known by users.
OBJECTIVE: To evaluate the understanding of the population on prostate cancer screening. DESIGN: Descriptive study. SETTING: Primary care teams in the province of Barcelona, Spain, from april to september 2005. PARTICIPANTS AND CONTEXT: Men between 50 and 70 years old without prostate symptoms and seen in the clinics of 12 primary care teams. METHOD: Systematic sample. VARIABLES: age, marital status, educational level, and self-perceived health status. Appraisal of knowledge through a 14-question questionnaire referring to the key ideas, previously defined by a group of experts, requisite before deciding on prostate cancer screening. RESULTS: N=221. Mean age, 59.9 (SD, 5.9); educational level, primary or lower: 63.4%; 89.1% (95% CI, 84.4-92.6) did not have sufficient knowledge about prostate cancer screening. In the questions on what PSA is and what it is for, over 50% said they did not know; 63.3% recognised that prostate cancer was a highly prevalent illness; 84.6% replied that early detection of prostate cancer avoids deaths; 49.8% did not know whether the doctor had doubts on this question; and 38.9% thought he didn't. There were no differences in knowledge for any of the variables studied. CONCLUSIONS: Although prostate cancer screening is widely known about, the information of the population is scant and often wrong. Existing scientific uncertainty on the use of screening is the aspect that is least known by users.
Authors: Grace Lu-Yao; Peter C Albertsen; Janet L Stanford; Therese A Stukel; Elizabeth S Walker-Corkery; Michael J Barry Journal: BMJ Date: 2002-10-05
Authors: M José Fernández de Sanmamed Santos; Mar Ballester Torrens; Ferran Ariza González; Josep Casajuana Brunet Journal: Rev Esp Salud Publica Date: 2007 May-Jun
Authors: Ingrid W van der Cruijsen-Koeter; Monique J Roobol; Mark F Wildhagen; T H van der Kwast; W J Kirkels; Fritz H Schröder Journal: Urology Date: 2006-09 Impact factor: 2.649
Authors: David M Radosevich; Melissa R Partin; Sean Nugent; David Nelson; Ann Barry Flood; Jeremy Holtzman; Nancy Dillon; Michele Haas; Timothy J Wilt Journal: Patient Educ Couns Date: 2004-08